Big development in medical science: This cheap and the most popular diabetes drug used worldwide could help fight colon cancer
A popular, inexpensive
diabetes medication
might have a strong new use. Scientists are now investigating a 20-cent wonder drug,
metformin
's potential to aid in the combat against colon cancer, and the early findings are encouraging.
#Operation Sindoor
Live Updates| From Sindoor to showdown? Track Indo-Pak conflict as it unfolds
India hits Lahore's Air Defence Radars in proportionate response
Pakistan tried to hit military targets in these 15 Indian cities, New Delhi thwarts strikes
This surprising turn of events may be a turning point, particularly since the drug is already widely used and fairly affordable. Experts are cautiously optimistic as the research continues.
Although not a cure on its own, initial research indicates that it can enhance other treatments, especially for hard-to-treat cancers. The drug's safety profile and low cost make it a good choice.
Continue to video
5
5
Next
Stay
Playback speed
1x Normal
Back
0.25x
0.5x
1x Normal
1.5x
2x
5
5
/
Skip
Ads by
Researchers who gave presentations at last week's American Association for Cancer Research conference in Chicago are examining the interactions between metformin, the most widely used diabetes drug globally, and difficult-to-treat colon cancer cells. They are still in the early stages of their research, as per a report by Business Insider.
Holli Loomans-Kropp, a gastrointestinal
cancer prevention
researcher at The Ohio State University who is spearheading the ongoing study, claimed that metformin "seems like it could have a really interesting supplemental approach to therapy." "We're opening up some doors to what this could do, as quoted in a report by Business Insider.
Live Events
How does metformin affect colon cancer cells?
According to earlier studies, colon cancer rates are lower among diabetics taking metformin, which may indicate that the medication is taking some preventative action against the development of cancer.
One of the first studies to examine whether metformin may actually combat colon cancer cells after the disease has progressed is this new one.
According to what Loomans-Kropp and her colleagues have observed thus far in cell-culture dishes, metformin may eventually prove to be a useful "supplement" to specific cancer treatment plans.
It could be used in conjunction with other treatments, but it wouldn't be strong enough to treat cancer on its own.
The drug's potential to treat a common type of colon cancer that is often difficult to treat due to a mutated
KRAS gene
excites Loomans-Kropp. Before human clinical trials can start, more animal testing is necessary, so her research is still in its early phases.
Why are researchers optimistic about metformin's potential?
The fact that metformin is a medication that is already widely available and reasonably priced makes it a practical choice for treating colon cancer, according to Loomans-Kropp.
Millions of people around the world have studied and taken metformin, which is inexpensive as an off-patent generic medication that costs 10 to 20 cents per pill. Because it controls how the body uses energy and promotes autophagy, which enables the body to break down old and damaged cells, some scientists think it may have potential as an antiaging medication.
According to Loomans-Kropp, metformin may also prevent colon cancer cells from utilising energy for growth and development.
What's next in the study before human trials begin?
Metformin as a disease prevention tool excites longitudinal researchers. Metformin may be a "suitable" option for cancer prevention, according to Dr. Nir Barzilai, a renowned longevity researcher who believes the medication may be helpful for healthy ageing.
Within a year, she can start testing metformin as a treatment for colon cancer in animals if these preliminary cancer cell results are positive.
FAQs
Does metformin cure colon cancer?
No, but it may supplement other treatments, particularly for aggressive forms of the disease.
Why is metformin being considered as a cancer treatment?
As it alters how cells use energy, it may slow cancer growth; additionally, it is inexpensive and already widely used.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Bupa weighs foray into private hospitals market in India
British health insurance major Bupa is looking to enter the fast-growing private hospital and healthcare market in India, currently dominated by players like Max Healthcare, Apollo Hospitals, Fortis, Narayana Health, and Medanta, as the company grows its engagement beyond the traditional insurance business (Niva Bupa), global CEO Inaki Ereno told TOI in an interview. Excerpts: How do you assess the Indian health insurance market in India? The Indian health insurance market is the most attractive and best in the world. It's still under-penetrated, and we believe there will be many more people requiring private medical insurance. We need more beds, more hospitals, more clinics, and more insurance here... In terms of our own growth, it's been 35% over the last three years. We're clearly seeing a massive opportunity. In markets like Europe, UK, Australia , Latin America, you have a Bupa Payvider programme where you provide not just insurance and easy claims processing, but also a network of healthcare providers. These include dental and mental health clinics, and hospitals. Any plans to start hospitals and such other services in India? With Payvider, we are not just insurers but also providers. Of the claims that our patients go through, we always want around 25% in a place called Bupa - in a Bupa clinic, in a Bupa hospital, in a Bupa digital place. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Buy Brass Idols - Handmade Brass Statues for Home & Gifting Luxeartisanship Buy Now Undo This helps us to learn the cost of things, and also allows us to personalise the service. It is too soon to talk about India. I cannot commit yet on the dates but, yes, you can expect that Bupa will keep investing here... we do have a plan, a commitment to study the situation and be ambitious and come up with something big. We believe that 25% of the activity that we do should be run in a place like Bupa. Inflation in health costs is a concern for customers, which also sees policy costs go up. Your views? When it comes to the cost of claims, there is inflation across the world. This is why developing a private medical insurance market helps everybody. When you have more people into private medical insurance, that helps lower costs of claims. Normally, premiums go up with inflation. So, they will not reduce. Are we expecting a big increase in premiums? The answer is no. We expect premiums to go in line with the Consumer Price Index (CPI). Apart from metros and bigger cities, how do you see the opportunity in Tier 2 and Tier 3 towns and rural India? We are clearly targeting markets beyond the top 50-60 cities. We think there's a massive opportunity to get people into the fold of insurance. India is at a very nascent stage, and awareness is still low with respect to health insurance. India is a growing country, with lots of construction and other infrastructure activities happening. Do you think that dust, pollution, and long traffic snarls in congested cities create health hazards for people? The answer is yes, though no one can make a direct correlation in elements like these. But we are working with the Norman Foster Foundation to understand what is the impact that living in a particular city has on your health, including in Delhi. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
India.com
3 hours ago
- India.com
Meet India's Deadliest Hypersonic Missile: Too Fast For Radars, Built To Smash Pakistan And China
New Delhi: India is preparing to test its most advanced hypersonic missile – Extended Trajectory - Long Duration Hypersonic Cruise Missile (E T-LDHCM). Developed entirely with indigenous technology under DRDO's secretive 'Project Vishnu', this missile is being touted as a strategic gamechanger capable of shifting power equations across Asia. The ET-LDHCM will give India the ability to strike deep inside enemy territory, be it Pakistan or China, within minutes and with devastating precision once it becomes operational. With a top speed of Mach 8, roughly 11,000 km/h or eight times the speed of sound, the missile can cover a distance of three kilometres in one second. This speed makes it nearly impossible for existing radar and air defense systems to intercept it. The ET-LDHCM is armed with a range of more than 1,500 kilometres and has the capacity to target and obliterate enemy installations with either nuclear or conventional payloads weighing between 1,000-2,000 kilogrammes. Its scramjet engine, an advanced propulsion system – which takes in air from the atmosphere to burn fuel, enables it to maintain hypersonic speeds for extended periods. It makes it lethal. The DRDO has already successfully conducted a ground test of the engine for a staggering 1,000 seconds. It shows India is not far from deploying this next-gen technology in real-world scenarios. Built for Stealth, Power and Versatility Different from ballistic missiles that follow predictable paths, the ET-LDHCM flies at low altitudes, can manoeuvre mid-flight and is constructed with heat-resistant materials that are capable of withstanding up to 2,000 degree Celsius. It also features oxidation-resistant coatings that ensure it remains functional in even the harshest environments – including saltwater and scorching sunlight. The ET-LDHCM's versatility sets it apart. It can be launched from land, air or sea, giving India unprecedented strategic flexibility. Whether targeting enemy radar stations, naval destroyers or strategic command centres, the missile's precision, range and evasion capabilities make it a nightmare for any adversary. Strategic Significance for India With the ET-LDHCM, India joins an elite club of nations, including the United States, Russia and China, that have mastered hypersonic missile technology. But what makes India's feat more significant is that the missile is a completely Make in India project, designed and built at the Dr. A.P.J. Abdul Kalam Missile Complex in Hyderabad in partnership with private Indian defense firms. This missile provides India with a clear tactical and strategic edge over Pakistan and China. The two nations continue to conduct aggressive missile tests and border provocations. It gives Indian forces the ability to execute surgical hypersonic strikes deep within enemy territory, potentially before the enemy even realises they have been hit. Moreover, beyond military use, mastering hypersonic technologies could boost India's capabilities in satellite launches, aerospace development and disaster response – all critical sectors for national growth. The programme also promises to create thousands of jobs and provide fresh opportunities for Indian MSMEs in the defense ecosystem. When and Where It Will Matter Whether it is a land-attack mission to destroy hardened military bunkers, a naval strike against aircraft carriers and destroyers or a deep strategic assault on enemy infrastructure, the ET-LDHCM is built to deliver lethal blows with incredible speed and minimal warning. In the new age of warfare, where milliseconds can decide outcomes, India's ET-LDHCM could very well be the silent supersonic sword that redefines deterrence and defense.
India Today
3 hours ago
- India Today
Wax statue of Sunita Williams in astronaut-style suit unveiled at Bengal's museum
A wax statue of astronaut Sunita Williams has been unveiled at the Susanta Ray Wax Museum in Asansol, West Bengal. The statue was officially inaugurated on Sunday by West Burdwan District Magistrate S Pannabalam and the state's Law and Labour Minister Malay the craftsmanship of artist Susanta Ray, the District Magistrate said, "Susanta Ray is not only the pride of this district but of the whole of Bengal. His wax art is of international standard. He is a priceless gem of Bengal."advertisementMinister Malay Ghatak said, "This artist has made a name for himself not only in Bengal but across India. I hope he becomes the best wax artist in the country." Sunita Williams, an American astronaut with ancestral roots in India, is celebrated for her extended stay aboard the International Space Station and for holding the record for one of the longest spacewalks by a about his inspiration, artist Susanta Ray said, "The idea to create Sunita Williams's statue came to me after she returned from space following a long nine months. She is the pride of our country. Her life story will inspire the new generation to explore science and space."The wax statue took nearly two months to complete, slightly longer than Roy's usual timeline of one and a half months per statue. The main challenge, he said, was obtaining the astronaut-style suit, which was sourced from the United States at a cost of Rs 10,000, with assistance from the director of the Jaipur Wax statue has been crafted to mirror Sunita Williams's actual height, facial features, and body posture. Her vibrant space uniform, accurately replicated, has already captivated audiences. Since the unveiling, the museum has seen a surge of visitors, with people of all ages taking selfies and sharing videos on social media. Visitors were particularly struck by the statue's striking resemblance and Sunita's smiling Susanta Ray Wax Museum currently houses over a hundred wax figures, including representations of Shah Rukh Khan, Sushant Singh Rajput, Virat Kohli, Mahatma Gandhi, and Amitabh Bachchan. The museum also features a mirrored gallery named 'Sheesh Mahal', which enhances the visitor experience with creative light Watch
